IS4982A - Milliefni til smíða á HIV-próteasatálmum og aðferðir til að smíða HIV-próteasatálma - Google Patents

Milliefni til smíða á HIV-próteasatálmum og aðferðir til að smíða HIV-próteasatálma

Info

Publication number
IS4982A
IS4982A IS4982A IS4982A IS4982A IS 4982 A IS4982 A IS 4982A IS 4982 A IS4982 A IS 4982A IS 4982 A IS4982 A IS 4982A IS 4982 A IS4982 A IS 4982A
Authority
IS
Iceland
Prior art keywords
construction
protease inhibitors
hiv protease
intermediates
methods
Prior art date
Application number
IS4982A
Other languages
English (en)
Other versions
IS2030B (is
Inventor
R. Whitten Kathleen
E. Deason Michael
Original Assignee
Agouron Pharmaceuticals, Inc
Japan Tobacco Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharmaceuticals, Inc, Japan Tobacco Inc. filed Critical Agouron Pharmaceuticals, Inc
Publication of IS4982A publication Critical patent/IS4982A/is
Publication of IS2030B publication Critical patent/IS2030B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/08—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/287—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12—Acetic acid esters
    • C07C69/14—Acetic acid esters of monohydroxylic compounds
    • C07C69/145—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols
    • C07C69/157—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62—Halogen-containing esters
    • C07C69/63—Halogen-containing esters of saturated acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS4982A 1996-09-05 1999-02-19 Milliefni til smíða á HIV-próteasatálmum og aðferðir til að smíða HIV-próteasatálma IS2030B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70841196A 1996-09-05 1996-09-05
PCT/US1997/015468 WO1998009951A2 (en) 1996-09-05 1997-09-04 Intermediates for making hiv-protease inhibitors and methods of making hiv-protease inhibitors

Publications (2)

Publication Number Publication Date
IS4982A true IS4982A (is) 1999-02-19
IS2030B IS2030B (is) 2005-08-15

Family

ID=24845703

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4982A IS2030B (is) 1996-09-05 1999-02-19 Milliefni til smíða á HIV-próteasatálmum og aðferðir til að smíða HIV-próteasatálma

Country Status (33)

Country Link
EP (2) EP1361216B1 (is)
JP (3) JP4149000B2 (is)
KR (1) KR100563289B1 (is)
CN (2) CN1183117C (is)
AP (2) AP1322A (is)
AT (2) ATE254603T1 (is)
AU (2) AU740369B2 (is)
BG (2) BG64793B1 (is)
BR (1) BR9713192A (is)
CA (1) CA2264756A1 (is)
CZ (2) CZ298175B6 (is)
DE (2) DE69734689T2 (is)
DK (2) DK1361216T3 (is)
EA (1) EA002051B1 (is)
EE (1) EE04465B1 (is)
ES (2) ES2210573T3 (is)
GE (1) GEP20022799B (is)
HK (1) HK1062171A1 (is)
HU (1) HUP0000028A3 (is)
IL (1) IL128567A (is)
IS (1) IS2030B (is)
NO (1) NO313287B1 (is)
NZ (1) NZ334909A (is)
OA (1) OA10988A (is)
PL (2) PL198408B1 (is)
PT (1) PT927165E (is)
SG (1) SG94780A1 (is)
SI (2) SI0927165T1 (is)
SK (2) SK284899B6 (is)
TR (1) TR199900473T2 (is)
UA (1) UA67727C2 (is)
WO (1) WO1998009951A2 (is)
YU (1) YU11599A (is)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0641038A (ja) * 1992-07-17 1994-02-15 Mitsubishi Kasei Corp カルボン酸誘導体
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
JPH07248183A (ja) * 1994-03-11 1995-09-26 Osaka Gas Co Ltd 浴室兼用衣類乾燥室
JP3298293B2 (ja) * 1994-03-14 2002-07-02 松下電器産業株式会社 厨芥処理機
AU4953796A (en) * 1995-03-15 1996-10-02 Sanyko Company, Limited Dipeptide compounds having ahpba structure
EP0983999B8 (en) * 1995-09-26 2005-06-08 Japan Tobacco Inc. Process for producing amide derivatives and intermediates
WO1997011938A1 (fr) * 1995-09-26 1997-04-03 Japan Tobacco Inc. Procede de production de derives amides et de leurs intermediaires
US5962704A (en) * 1995-09-26 1999-10-05 Japan Tobacco Inc. Production of amide derivatives and intermediate compounds therefor
CZ230398A3 (cs) * 1996-02-24 1999-01-13 Basf Aktiengesellschaft Derivát pyrazol-4-ylhetaroylu, způsob jeho přípravy a herbicidní prostředek, který ho obsahuje

Also Published As

Publication number Publication date
CZ71699A3 (cs) 1999-06-16
ATE254603T1 (de) 2003-12-15
TR199900473T2 (xx) 1999-06-21
SI0927165T1 (en) 2004-04-30
PL198408B1 (pl) 2008-06-30
CN1537846A (zh) 2004-10-20
PL331801A1 (en) 1999-08-02
UA67727C2 (uk) 2004-07-15
PL201758B1 (pl) 2009-05-29
BG65237B1 (bg) 2007-09-28
DK1361216T3 (da) 2006-01-23
NZ334909A (en) 2000-06-23
CZ298175B6 (cs) 2007-07-11
WO1998009951A2 (en) 1998-03-12
AP9901497A0 (en) 1999-06-30
EE04465B1 (et) 2005-04-15
SK28299A3 (en) 1999-11-08
ES2252586T3 (es) 2006-05-16
EA002051B1 (ru) 2001-12-24
PT927165E (pt) 2004-04-30
SK284899B6 (sk) 2006-02-02
HUP0000028A3 (en) 2003-05-28
EA199900257A1 (ru) 1999-08-26
SI1361216T1 (sl) 2006-02-28
JP2001500495A (ja) 2001-01-16
EP0927165A2 (en) 1999-07-07
KR20010029489A (ko) 2001-04-06
CN1232455A (zh) 1999-10-20
DE69726298T2 (de) 2004-05-27
IS2030B (is) 2005-08-15
DE69726298D1 (de) 2003-12-24
CN1183117C (zh) 2005-01-05
AU766155B2 (en) 2003-10-09
EP1361216A1 (en) 2003-11-12
AU740369B2 (en) 2001-11-01
OA10988A (en) 2001-11-01
AP2003002938A0 (en) 2003-12-31
EP0927165B1 (en) 2003-11-19
SK285278B6 (sk) 2006-10-05
YU11599A (sh) 2000-03-21
DK0927165T3 (da) 2004-03-15
GEP20022799B (en) 2002-09-25
AP1322A (en) 2004-11-04
NO991072D0 (no) 1999-03-04
KR100563289B1 (ko) 2006-03-22
CA2264756A1 (en) 1998-03-12
IL128567A (en) 2004-03-28
AU1473602A (en) 2002-03-14
JP4149000B2 (ja) 2008-09-10
NO313287B1 (no) 2002-09-09
BG64793B1 (bg) 2006-04-28
NO991072L (no) 1999-03-04
BG103305A (en) 2000-01-31
CN1305854C (zh) 2007-03-21
EP1361216B1 (en) 2005-11-16
WO1998009951A3 (en) 1998-07-09
SG94780A1 (en) 2003-03-18
AU4331797A (en) 1998-03-26
IL128567A0 (en) 2000-01-31
ES2210573T3 (es) 2004-07-01
EE9900109A (et) 1999-12-15
HUP0000028A2 (hu) 2000-05-28
DE69734689D1 (de) 2005-12-22
CZ298174B6 (cs) 2007-07-11
ATE309990T1 (de) 2005-12-15
JP2008056693A (ja) 2008-03-13
JP2008088178A (ja) 2008-04-17
BR9713192A (pt) 1999-12-21
HK1062171A1 (en) 2004-10-21
DE69734689T2 (de) 2006-06-08

Similar Documents

Publication Publication Date Title
NO985820D0 (no) Cytokinproduksjonsinhibitor, triazepinforbindelse og mellomprodukter for disse
NO990759L (no) Heterocykliske metallproteaseinhibitorer
NO995433D0 (no) Protease-inhibitorer
NO990296D0 (no) HPPD-genet og inhibitorer
PT936912E (pt) Inibidores de cisteina protease
IS4928A (is) Fosfín tengdir tálmar af grindar málmpróteösum
NO981938D0 (no) Proteaseinhibitorer
NO992734L (no) Serin-protease inhibitorer
DK0944590T3 (da) Aminoguanidiner og alkoxyguanidiner som proteaseinhibitorer
NO983688D0 (no) Serin-protease-inhibitorer
NO990856L (no) Spirosykliske metallprotease-inhibitorer
NO995434L (no) Proteaseinhibitorer
NO995435D0 (no) Protease-inhibitorer
DE69730871D1 (de) Serine-protease-inhibitoren
NO995268D0 (no) Proteaseinhibitorer
DE69714222D1 (de) Serine-protease-inhibitoren
IS4980A (is) Aðferðir og milliefni við framleiðslu á setnum krómanól afleiðum
IS5356A (is) Viss bensóþíasíndíoxíð-mótlyf gegn endóþelíni og ferli til að smíða þau
IS2273B (is) Aðferð fyrir nýsmíðina á HIV próteasa lötum
DK0905128T3 (da) Fremgangsmåder og mellemprodukter egnede til fremstilling af antifolater
DK0983249T3 (da) Fremgangsmåder og mellemprodukter til fremstilling af substituerede indazolderivater
IS2030B (is) Milliefni til smíða á HIV-próteasatálmum og aðferðir til að smíða HIV-próteasatálma
IS4943A (is) Aðferð til að búa til naftýridón og milliefni
NO994415D0 (no) HIV proteaseinhibitorer
DK0981524T3 (da) Nye mellemprodukter og fremgangsmåde til fremstilling deraf